Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Merck KGaA eyes up to 700 million euro Mavenclad sales in EU

      Merck KGaA eyes up to 700 million euro Mavenclad sales in EU

      Ruby Khatun Khatun2 Oct 2017 9:20 AM IST
      FRANKFURT: Germany’s Merck KGaA is eyeing annual sales of its multiple sclerosis pill Mavenclad, a late-comer to the market for oral treatments...
      Spire Healthcare appoints Justin Ash as CEO

      Spire Healthcare appoints Justin Ash as CEO

      Ruby Khatun Khatun2 Oct 2017 9:00 AM IST
      Britain’s second-largest healthcare firm Spire Healthcare Group Plc on Wednesday appointed former Oasis Healthcare CEO Justin Ash as its chief...
      SMT launches next generation Supralimus Grace drug eluting stent in India

      SMT launches next generation Supralimus Grace drug eluting stent in India

      Ruby Khatun Khatun1 Oct 2017 11:15 AM IST
      Mumbai: SMT, One of the largest stent manufacturing company in India, has recently announced the launch and widespread availability plans for its...
      Eli Lilly gets FDA approval for breast cancer drug

      Eli Lilly gets FDA approval for breast cancer drug

      Ruby Khatun Khatun1 Oct 2017 10:30 AM IST
      The U.S. Food and Drug Administration (FDA) said on Thursday it approved an Eli Lilly and Co drug to treat advanced breast cancer that has progressed...
      AbbVie, Amgen settlement sets Humira US biosimilar launch for 2023

      AbbVie, Amgen settlement sets Humira US biosimilar launch for 2023

      Ruby Khatun Khatun1 Oct 2017 10:01 AM IST
      Amgen Inc has reached a settlement with AbbVie Inc that will delay the U.S. launch of Amgen’s cheaper biosimilar version of AbbVie’s cash cow, the...
      EU approves Sanofi and Regenerons dupilumab in eczema

      EU approves Sanofi and Regenerons dupilumab in eczema

      Ruby Khatun Khatun1 Oct 2017 9:45 AM IST
      PARIS: The European Commission approved Regeneron Pharmaceuticals’ and Sanofi’s key biologic treatment dupilumab for moderate-to-severe atopic...
      WHO tells governments to reject Philip Morris-funded smoking foundation

      WHO tells governments to reject Philip Morris-funded smoking foundation

      Ruby Khatun Khatun1 Oct 2017 9:20 AM IST
      GENEVA: The World Health Organization (WHO) told governments on Thursday not to get involved in a foundation funded by tobacco firm Philip Morris...
      Great News: Serum Institutes vaccine Rotavirus Gastroenteritis shows efficacy

      Great News: Serum Institutes vaccine Rotavirus Gastroenteritis shows efficacy

      Ruby Khatun Khatun1 Oct 2017 9:17 AM IST
      Pune: Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd.’s rotavirus vaccine BRV-PV (known as ROTASIIL®) were...
      Soon, customised drugs to be printed on site

      Soon, customised drugs to be printed on site

      Ruby Khatun Khatun30 Sept 2017 11:40 AM IST
      Washington: Scientists, including those of Indian origin, have developed a technology that can print pure, ultra-precise doses of drugs onto a wide...
      Hilleman Labs gets grant to develop oral cholera vaccine

      Hilleman Labs gets grant to develop oral cholera vaccine

      Ruby Khatun Khatun30 Sept 2017 10:57 AM IST
      New Delhi: Hilleman Laboratories, a joint- venture partnership between pharma major MSD and Wellcome Trust, said it has received 6 million krona (over...
      Pharma companies lag in digital journey against global counterparts: EY

      Pharma companies lag in digital journey against global counterparts: EY

      Ruby Khatun Khatun30 Sept 2017 10:39 AM IST
      MUMBAI: Indian pharmaceutical companies lag behind in their digital journey as compared to their global counterparts, according to an industry...
      Zydus Cadila gets final nod from USFDA for anti-bacteria drug

      Zydus Cadila gets final nod from USFDA for anti-bacteria drug

      Ruby Khatun Khatun30 Sept 2017 10:14 AM IST
      New Delhi: Drug firm Zydus Cadila has received final approval from the US health regulator to market doxycycline tablets, used for the treatment of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok